Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin

Clinical trial NCT05201079 · COMPLETED

Trial details

NCT number: NCT05201079
Sponsor: Mikrobiomik Healthcare Company S.L.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Clostridium Difficile Infection Primary Clostridium Difficile Infection

Start date: 2021-10-29
Primary completion: 2023-11-15
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.